Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered.
"Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50," Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).
On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below $25 per dose.
"Nothing is signed yet, but we're close to a deal with the EU Commission. We want to deliver to Europe and are in constructive talks," Bancel told WamS, adding it was just a "matter of days" until a contract would be ready.
Moderna has said its experimental vaccine is 94.5 per cent effective in preventing COVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.
The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July.
US President Donald Trump has paused new tariffs on Mexico for one month after Mexico agreed to reinforce its northern border with 10,000 National Guard members to stem the flow of illegal drugs, particularly fentanyl, he said on Monday.
Families boarded ferries and extra flights were laid on to help people leave Santorini on Monday as dozens of tremors shook the Greek island for a fourth day.
A bomb tore through the lobby of a luxury apartment block in Moscow on Monday, killing at least one person and injuring four others in an attack targeting a pro-Russian paramilitary leader from eastern Ukraine, the state TASS news agency reported.
A car bomb killed at least 15 people in the Syrian city of Manbij on Monday, the second attack there in three days and Syria's deadliest since Bashar al-Assad was toppled from power in December.
President Donald Trump said the sweeping tariffs that he has imposed on Mexico, Canada and China may cause "short term" pain for Americans as global markets reflected concerns the levies could undermine growth and reignite inflation.